[Immuno-Oncology Newsletter - Edition 9]

Immuno-Oncology Insights: Fuel Your Summer of Discovery

As immuno-oncology research evolves at pace, staying ahead means having the right tools at hand. This month, discover our latest high-impact solutions—from self-amplifying RNA reporters and immune-responsive biomaterials, to cutting-edge tools for γδ T cell-based immunotherapy.

Before the summer slowdown, take a moment to explore how Tebubio can help you move faster, think further, and refine your experimental strategy.

We’ll be back in September—until then, let’s keep pushing the science forward.

Upcoming Webinar

Webinar On-Demand—Unlock the Future of Adoptive Cell Therapy

Discover how to accelerate your CAR and TCR-T cell projects with a cutting-edge suite of tools, now available to watch at your convenience. This webinar on-demand offers practical insights into using primary human immune cells and functional assays to validate target recognition, T cell activation, and effector functions. 

Learn how our latest innovations support HLA allele screening—key for advancing TCR engineering. Designed with researchers in mind, this session is rich in real-world applications and scientific guidance. Whether you're just starting or optimising advanced workflows, find out how these tools can elevate your research. 

Tebubio Contract Research Services

New Poster Now Available—Advancing RNA Delivery in Oncology

Presented at AACR 2025, our latest poster showcases how Tebubio’s Contract Research Services (CRS) platforms enables real-time tracking of RNA delivery using fluorescent lipid nanoparticles. 

Developed in collaboration with Echelon Biosciences and patient-derived models, this work reflects our CRS expertise in supporting oncology research from RNA design to in vitro validation.

Stimulus solutions

New Tools for Self-Amplifying RNA Research – TriLink’s saRNA Reporters Now Available

Self-amplifying RNA (saRNA) is gaining momentum in vaccine development, gene therapy, and translational research, yet studying its expression remains technically challenging.

​TriLink​’s new saRNA reporters, now available via Tebubio, offer a robust, ready-to-use solution for tracking expression in vitro and in vivo.

Whether optimising delivery systems or studying saRNA kinetics, these tools provide enhanced sensitivity and seamless workflow integration for next-generation RNA research.

Models solutions

Unlock the Potential of Gamma Delta T Cells in Cancer Therapy

Gamma Delta (γδ) T cells are emerging as powerful players in cancer immunotherapy, thanks to their unique ability to recognize and destroy tumor cells.

Discover how BPS Bioscience supports your research with innovative tools to explore γδ TCR-based therapeutic strategies.

Analysis solutions

Unlocking Bone Healing: Reprogram Macrophage Metabolism for Better Osseointegration

The success of orthopaedic implants in osteoporotic patients remains a significant clinical challenge. Emerging research highlights the pivotal role of macrophage metabolism in regulating bone regeneration and implant integration. By modulating macrophage function, scientists are uncovering novel strategies to promote a pro-healing environment at the bone-implant interface.

Explore the latest insights into immune-metabolic reprogramming and its potential to transform osteointegration outcomes in compromised bone with Dojindo's products.

We facilitate Life Sciences Research daily, advancing Science for a brighter future with comprehensive biological solutions from top global suppliers to accelerate your research projects.

If you lack time or expertise, our CRS team can support you with mRNA production, cell line engineering, protein production, cellular studies, and biomarker analysis.

With Tebubio, concentrate your efforts and accelerate what’s most important to you: your research.

Stay Ahead in Immuno-Oncology

Subscribe to our monthly newsletter for the latest breakthroughs, expert insights, and exclusive updates in immuno-oncology.